Fasitibant chloride hydrochloride

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameFasitibant chloride hydrochloride
Drug Alias Name盐酸氯法西替班chlorure de fasitibantcloruro de fasitibant氯法西替班盐酸盐fasitibanti chloridum +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBradykinin B2 receptor antagonists
TargetsBradykinin B2 receptor
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesItaly +[6] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMenarini
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMenarini Group
Active IndicationsN/A
Inactive IndicationsOsteoarthritis, Knee

Other Information

ATC CodeN/A
Related LinksN/A